Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.04B | $982.9M | $937.8M | $1.12B | $1.08B | $961.5M | $930.6M | $965.4M |
| Cost of revenue | $149.5M | $149.6M | $318.7M | $175.3M | $204.1M | $655.5M | $239.4M | $0 |
| Gross profit | $891.4M | $833.3M | $619.1M | $942.3M | $875.6M | $306.0M | $691.2M | $0 |
| Gross margin | 85.6% | 84.8% | 66.0% | 84.3% | 81.1% | 31.8% | 74.3% | 0.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $427.5M | $368.2M | −$105.2M | $386.1M | $303.0M | $173.4M | −$1.39B | $28.8M |
| EBITDA | $813.9M | $786.3M | $192.4M | $815.0M | $158.3M | $651.9M | −$1.01B | $553.2M |
| Net income | $36.2M | $9.7M | −$529.6M | $102.1M | −$572.9M | −$91.7M | −$1.65B | −$284.3M |
| Net margin | 3.5% | 1.0% | -56.5% | 9.1% | -53.1% | -9.5% | -176.9% | -29.4% |
| EPS (diluted) | 11.60 | 3.11 | -44.80 | 6.40 | -36.00 | -5.60 | -101.92 | -17.30 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $972M | $-10.67 | $-10.67–$-10.67 | 1 |
| 2027 | $1.0B | $-12.58 | $-12.58–$-12.58 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds MPLN.
No tracked institution reports a position in MPLN as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-09-23 | 1-for-40reverse |
No one on the platform has traded MPLN yet.
| $380M |
| — |
| RVNCRevance Therapeutics, Inc. | $3.65 | +0.00% | $381M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$MPLN 3 months wiped out in 2 days, nice. Somebody knows something
View on StockTwits ↗$MPLN has been a scam from the get go. Klein is a spac scammer. $CCIX
View on StockTwits ↗@MrMonopolyMan yeah he got me good on $MPLN Crooks. Avoid.
View on StockTwits ↗$MPLN Wow. I can't stop adding. Charts looking really good as always
View on StockTwits ↗$MPLN not an offering to public … it should be a net net positive once ppl figure it out ..
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Trading at 0.4× sales vs its 1.0× historical median P/S.
Fair value ≈ $56.34 · price $23.15 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.